DATELINE / SUBHEAD
July 19, 2026 · New York Medical College, Valhalla, NY
INTRODUCTION
On July 19, General Nutraceutical Technology (GNT) was proud to take part in Evidence-Based Integrative Health for Immunology and Wellness: Clinical Practice, Science & Technology — a symposium hosted at New York Medical College and chaired by GNT founder Dr. Xiu-Min Li. Two scientists from our R&D Division, Dr. Nan Yang and Dr. Michelle Carnazza, presented alongside leading clinicians and researchers from institutions including NYU, UCSF, Massachusetts General Hospital, and the NIH
SECTION 1 — Quality Control of Herbal Medicines Using Bioanalytical Techniques
Nan Yang, PhD — Senior Scientist, R&D Division
Botanical products are only as good as the science behind them. Dr. Yang walked the audience through the real-world challenges of botanical quality control — natural variability between harvests, processing differences, and the sheer chemical complexity of multi-herb formulas — and showed how GNT meets each of them. He detailed our end-to-end program: authentication of raw herbs, HPTLC and HPLC/LC-MS fingerprinting, and heavy-metal, pesticide, and microbial testing carried out to USP and FDA standards, followed by in vitro and in vivo confirmation of the finished product. The result is botanical medicine with consistent identity, safety, and potency, batch after batch.
SECTION 2 — Probiotics for Food Allergy Treatment
Michelle Carnazza, PhD — Division of Research & Development
Food allergy is an IgE-mediated disease affecting roughly 33 million Americans, yet treatment options remain limited. Dr. Carnazza presented GNT’s research at the intersection of the gut microbiome and allergic disease — explaining how a healthy, balanced microbiome supports immune tolerance, how its disruption is linked to allergy, and how restoring beneficial bacteria can calm allergic responses. She then introduced GNT’s integrative innovation: pairing probiotics and fermented foods with active compounds our team has identified from traditional herbs — such as berberine, xanthopurpurin, and arctigenin — into a next-generation combination approach to reducing IgE and allergic symptoms.
CLOSING PARAGRAPH
Together, these talks capture what GNT does best — bridging the wisdom of traditional botanical medicine with rigorous modern analytics and immunology. We’re proud to help build the evidence base for integrative approaches to allergic and inflammatory disease, and we thank Dr. Li and the organizing committee for a remarkable day of science.